The role of Na+-H+ exchanger isoform 1 in aldosterone-induced glomerulosclerosis in vivo

Renal Failure

Volumn 31, Issue 8, 2009, Pages 726-735

  Zhang, Minmin ^a   Chen, Jing ^a   Liu, Shaojun ^a   You, Li ^a   Lin, Shanyan ^a   Gu, Yong ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Aldosterone; Fibronectin; Na+ H+ exchanger isoform 1; PCNA; TGFb1

Indexed keywords

ALDOSTERONE; CREATININE; SODIUM PROTON EXCHANGE PROTEIN 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FIBROSING ALVEOLITIS; GLOMERULOSCLEROSIS; HYPERTENSION; IMMUNOHISTOCHEMISTRY; KIDNEY MASS; MALE; NEPHRECTOMY; NONHUMAN; OSMOTIC PUMP; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEINURIA; RAT; SHAM PROCEDURE; SYSTOLIC BLOOD PRESSURE;

ALDOSTERONE; ANIMALS; CATION TRANSPORT PROTEINS; FIBROSIS; GLOMERULONEPHRITIS; MALE; NEPHRECTOMY; RATS; RATS, SPRAGUE-DAWLEY; RENAL AGENTS; SODIUM-HYDROGEN ANTIPORTER;

EID: 70350641930     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/08860220903134571     Document Type: Article

References (38)

1. Stier CT Jr, Rocha R, Chander PN. Effect of aldosterone and MR blockade on the brain and the kidney. Heart Fail Rev. 2005;10:53-62.
2. Marney AM, Brown NJ. Aldosterone and end-organ damage. Clin Sci. 2007;113(6):267-278.
3. Young MJ. Mechanisms of mineralocorticoid receptor-mediated cardiac fibrosis and vascular inflammation. Curr Opin Nephrol Hypertens. 2008;17:174-180.
4. Lai L, Chen J, Hao CM, Lin S, Gu Y. Aldosterone promotes fibronectin production through a Smad2-dependent TGF-b1 pathway in mesangial cells. Biochem Biophys Res Comm. 2006;348:70-75.
5. Karmazyn M, Sawyer M, Fliegel L. The Na+/H+ exchanger: A target for cardiac thearapeutic intervention. Current Drug Targets-Cardiovascular and Haematological Disorders. 2005;5:323-335.
6. Baartscheer A, Schumacher CA, van Borren MM, Belterman CN, et al. Chronic inhibition of Na+/H+-exchanger attenuates cardiac hypertrophy and prevents cellular remodeling in heart failure. Cardiovasc Res. 2005;65:83-92.
7. Huang W, Xu C, Kahng KW, Noble NA, Border WA, Huang Y. Aldosterone and TGF-b1 synergistically increase PAI-1 and decrease matrix degradation in rat renal mesangial and fibroblast cells. Am J Physiol Renal Physiol. 2008;294: F1287-F1295.
8. Yuan J, Jia R, Bao Y. Beneficial effects of spironolactone on glomerular injury in streptozotocin-induced diabetic rats. J Renin Angiotensin Aldosterone Syst. 2007;8:118-126.
9. Nishioka T, Suzuki M, Onishi K, Takakura N, et al. Eplerenone attenuates myocardial fibrosis in the angiotensin II-induced hypertensive mouse: Involvement of tenascin-C induced by aldosterone-mediated inflammation. J Cardiovasc Pharmacol. 2007;49:261-268.
10. Chun TY, Chander PN, Kim JW, Pratt JH, Stier CT Jr. Aldosterone, but not angiotensin II, increases profibrotic factors in kidney of adrenalectomized stroke-prone spontaneously hypertensive rats. Am J Physiol Endocrinol Metab. 2008;295:E305-E312.
11. Nagai Y, Yao L, Kobori H, et al. Temporary angiotensin II blockade at the prediabetic stage attenuates the development of renal injury in type 2 diabetic rats. J Am Soc Nephrol. 2005;16:703-711.
12. Fan Y-Y, Baba R, Nagai Y, et al. Augmentation of intrarenal angiotensin II levels in uninephrectomized aldosterone/ salt-treated hypertensive rats: Reno-protective effects of the ultrahigh dose of olmesartan. Hypertens Res. 2006; 29:169-178.
13. Kobori H, Ozawa Y, Suzaki Y, Nishiyama A. Enhanced intrarenal angiotensinogen contributes to early renal injury in spontaneously hypertensive rats. J Am Soc Nephrol. 2005; 16:2073-2080.
14. Li C, Yang CW, Park CW, et al. Long-term treatment with ramipril attenuates renal osteopontin expression in diabetic rats. Kidney Int. 2003;63:454-463.
15. Teraishi K, Kurata H, Nakajima A, Takaoka M, Matsumura Y. Preventive effect of Y-27632, a selective Rho-kinase inhibitor, on ischemia/reperfusion- induced acute renal failure in rats. Eur J Pharmacol. 2004;505:205-211.
16. Anderson S, Meyer TW, Rennke HG, Brenner BM. Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass. J Clin Invest. 1985;76:612-619. (Pubitemid 15227525)
17. Lax DS, Benstein JA, Tolbert E, et al. Effects of salt restriction on renal growth and glumerular injury in rats with remnant kidneys. Kidney Int. 1992;41:1527-1534.
18. Hené RJ, Boer P, Koomans HA, Mees EJ. Plasma aldosterone concentrations in chronic renal disease. Kidney Int. 1982;21:98-101.
19. Fredersdorf S, Endemann DH, Luchner A, et al. Increased aldosterone levels in a model of Type 2 diabetes mellitus. Exp Clin Endocrinol Diabetes. 2009;117:15-20.
20. Sato A, Hayashi K, Naruse M, Saruta T. Effectiveness of aldosterone blockade in patients with diabetic nephropathy. Hypertension. 2003;41:64-68.
21. Hou FF, Zhang X, Zhang GH, et al. Efficacy and safety of benazepril for advanced chronic renal insufficiency. N Engl J Med. 2006;354:131-140.
22. Terada Y, Kuwana H, Kobayashi T, et al. Aldosterone-stimulated SGK1 activity mediates profibrotic signaling in the mesangium. Journal of the American Society of Nephrology. 2008;19:298-309.
23. Harguindey S, Orive G, Luis Pedraz J, Paradiso A, Reshkin SJ. The role of pH dynomics and the Na+/H+ antiporter in the etiopathogenesis and treatment of cancer. Two faces of the same coin-one single nature. Biochimica et Biophysica Acta. 2005;1756:1-24.
24. Baartscheer A, Hardziyenka M, Schumacher CA, et al. Chronic inhibition of the Na+/H+ - exchanger causes regression of hypertrophy, heart failure, and ionic and electrophysiological remodelling. Br J Pharmacol. 2008;154:1266-1275.
25. Navarro-Lopez F, Coca A, Pare JC, et al. Left ventricular hypertrophy in asymptomatic essential hypertension: Its relationship with aldosterone and the increase in sodium-proton exchanger activity. European Heart Journal. 1993;14:38-41.
26. Karmazyn M, Liu Q, Gan XT, Brix BJ, Fliegel L. Aldosterone increases NHE-1 expression and induces NHE-1-dependent hypertrophy in neonatal rat ventricular myocytes. Hypertension. 2003;42:1171-1176. (Pubitemid 37549073)
27. Ebata S, Muto S, Okada K, et al. Aldosterone activates Na+/ H+ exchange in vascular smooth muscle cells by nongenomic and genomic mechanisms. Kidney Int. 1999;56:1400-1412.
28. Pinto V, Pinho MJ, Hopfer U, Jose PA, Soares-da-Silva P. Oxidative stress and the genomic regulation of aldosteronestimulated NHE1 activity in SHR renal proximal tubular cells. Mol Cell Biochem. 2008;310:191-201.
29. Nangaku M. Mechanisms of tubulointerstitial injury in the kidney: Final common pathways to end-stage renal failure. Intern Med. 2004;43:9-17. (Pubitemid 38208370)
30. Takeda M, Tatsumi T, Matsunaga S, et al. Spironolactone modulates expressions of cardiac mineralocorticoid receptor and 11b-hydroxysteroid dehydrogenase 2 and prevents ventricular remodeling in post-infarct rat hearts. Hypertens Res. 2007;30:427-437.
31. Funder JW, Mihailaidou AS. Aldosterone and mineralocorticoid receptors: Clinical studies and basic biology. Mol Cell Endocrinol. 2009;301:2-6.
32. Kagami S, Border WA, Miller DE, Noble NA. Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-b expression in rat glomerular mesangial cells. J Clin Invest. 1994;93:2431-2437.
33. Anderson PW, Zhang XY, Tian J, et al. Insulin and angiotensin II are additive in stimulating TGF-b1 and matrix mRNAs in mesangial cells. Kidney Int. 1996;50:745-753.
34. Uchiyama-Tanaka Y, Matsubara H, Mori Y, et al. Involvement of HB-EGF and EGF receptor transactivation in TGFb- mediated fibronectin expression in mesangial cells. Kidney Int. 2002;62:799-808.
35. Guo B, Koya D, Isono M, Sugimoto T, Kashiwagi A, Haneda M. Peroxisome proliferator-activated receptor-c ligands inhibit TGF-b1-induced fibronectin expression in glomerular mesangial cells. Diabetes. 2004;53:200-208.
36. Reiss K, Meggs LG, Li P, Olivetti G, Capasso J, Anversa P. Upregulation of IGF1, IGF1-receptor, and late growthrelated genes in ventricular myocytes acutely after infarction in rats. J Cell Physiol. 1994;158:160-168.
37. Johnson RJ, Alpers CE, Yoshimura A, et al. Renal injury from angiotensin II-mediated hypertension. Hypertension. 1992;19:464-474.
38. Peng H, Carretero OA, Raij L, Yang F, Kapke A, Rhaleb NE. Antifibrotic effects of N-acetyl-seryl-aspartyl-Lysyl-proline on the heart and kidney in aldosterone-salt hypertensive rats. Hypertension. 2001;37:794-800.